MedTech Innovator announced Flosonics Medical as one of 50 companies selected to participate in the organization’s flagship four-month program, which will offer access to leading manufacturers, providers, investors, and other industry stakeholders.

The Medical Innovation Xchange is Canada's first industry-led hub dedicated to supporting southern Ontario medtech start-ups achieve global scale while keeping their headquarters in Waterloo Region, and will house anchor tenant Intellijoint Surgical who will be joined by Penta Medical, Vena Medical, and Bloom Care Solutions.

Spiderwort announced the raise of $500,000 CAD as part of its oversubscribed Friends and Family round, along with naming new advisory board members.

The Export Business Services Branch (EBSB), Ontario Ministry of Economic Development, Job Creation and Trade, is organizing a Trade Mission to attend the AdvaMed MedTech Conference in order to facilitate introductions for Ontario companies to potential customers, partners and investors.

The Canadian Technology Accelerator (CTA) initiative helps Canadian companies with an existing technology, product or service explore opportunities in foreign markets. Life Science sector sessions run in Boston, San Francisco, and Singapore.

This Partnership Development Activity mission will focus on introducing Canadian SMEs to potential Brazilian partners for industrial R&D collaboration specific to nanotechnology with applications to the biotechnology, medicine, pharmaceuticals and cosmetics sectors.

Thornhill Medical's investigative tool RespirAct™ Gas Control System contributed to international team led by scientists from Lawson Health Research Institute and Cedars-Sinai Medical Center.

The Hospital for Sick Children announced a $100-million donation made by Mattamy Homes founder Peter Gilgan, the largest single donation in the hospital’s history.

FACIT announced a new commercialization milestone with $750M in follow-on financing and partnerships attracted by its seed investment portfolio.

Antibe Therapeutics announced the lead indication for its second pipeline drug, ATB-352, a potent and non-addictive analgesic for the treatment of severe pain.

The Medventions internship program is a fast-paced, project-based training structure for students and recent graduates with a passion for entrepreneurship and a commitment to improving health care for patients around the world through technology innovation and commercialization.

Cyclica has announced its novel, first-in-class drug design technology, Ligand DesignTM which empowers scientists in the pharmaceutical industry to generate novel drug-like compounds by combining powerful methods for molecule generation, ADMET prediction, and high-throughput ligand-protein interaction prediction.

Philanthropists Charles and Margaret Juravinski will create an endowment of more than $100 million to equally support Hamilton Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton by funding health research in a variety of areas including cancer, mental health, lung and respiratory care, and diseases of aging.

Medtech Canada (formerly MEDEC) received assistance from Global Affairs Canada to provide financial support for 10 Canadian medtech companies to participate at the AdvaMed MedTech Conference in Boston.

Cohesys and Braze Mobility were selected as 2019 TiE50 Winners in the prestigious TiE50 Awards Program. This awards competition, now in its tenth year, is a program of TiEcon, the world's largest conference for tech entrepreneurs.

Forcen (formerly SensOR Medical Laboratories), raised $500K in seed funding led by NorthSpring Capital Partners with participation from a syndicate of angel investors from Golden Triangle Angel Network (GTAN) and Angel One.

The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced an investment of $49 million into the Industry Consortium for Image-Guided Therapy (ICIGT), a pan-Canadian network led by Sunnybrook that will transform Canada’s image-guided therapy industry into a global leader by integrating artificial intelligence into imaging-based medical technologies.